Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/04 → 9/30/07 |
A Phase I Safety and Tolerability Study of Peri-Lymphatically Ultralow Dose IRX-2 in Patients with Squamous Cell Carcinoma of the Head and Neck Who Have Failed Surgery And/Or Radiation Therapy
- Kenady, Daniel (PI)